TrialCell reports. Medicine2026

Precision neoadjuvant treatment with AI-assisted subtyping in HR+/HER2-breast cancer: A randomized, phase 2 trial FASCINATE-N.

Jun-Jie Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.